Dr. Daniel Andres Dicesare, MD

Dr. Dicesare practices at Orange Coast Dermatology, Inc in Rancho Santa Margarita, California.

Dr. Dicesare's NPI, 1902859093, was assigned on May 18, 2006. Dr. Dicesare graduated from Texas Tech University Health Sciences Center School of Medicine in 1995. Dr. Dicesare holds California license A83696.

Dr. Dicesare's primary practice is Orange Coast Dermatology, Inc, at 22032 El Paseo, Rancho Santa Margarita, CA 92688 in Orange County. The practice phone is (949) 364-3305.

Dr. Dicesare's primary practice is Orange Coast Dermatology, Inc in Rancho Santa Margarita, California. The medical group on file is Orange Coast Dermatology. Dmand AI also links Dr. Dicesare to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dicesare practices. Vendor and product names are available with a free account.

Procedural dermatology is Dr. Dicesare's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. Dicesare is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dicesare's licenses on file in 2 states: California and Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Dicesare treats.

CMS data shows 6,261 Medicare services from Dr. Dicesare across 27 procedure codes in 2024, for 581 Medicare patients. Medicare paid $329,685 for them. Every service was in an office.

CMS counts 581 Medicare patients who saw Dr. Dicesare in 2024. The largest group is 65 to 74, with 353 patients. 75% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dicesare's median patient age at 64, with 51% women.

In 2024, Dr. Dicesare wrote 380 Medicare Part D claims for 165 patients. 98% of them were for generic drugs. CMS names the drug for 291 of them, across 7 drugs with 11 or more claims each, at $3,303 in total drug cost. In 2023, CMS named 385 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Dicesare for performance year 2024, reported individually. Dr. Dicesare accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,792 procedures of removal of skin lesions by Dr. Dicesare, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Dicesare. The most frequent topics are Diarrhea and Travel. Dr. Dicesare's most frequent co-authors are Herbert Lancashire Dupont, MD and Steven B. Porter, MD.

CMS Open Payments shows 125 general payments to Dr. Dicesare from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $788.

Dmand AI lists 1 award for Dr. Dicesare.

Dr. Dicesare graduated from Texas Tech University Health Sciences Center School of Medicine in 1995. Dr. Dicesare is a member of AAD.

Dr. Dicesare is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.